Wellumio is a company headquartered in New Zealand.
Wellumio develops Axana, a portable, AI-enhanced magnetic resonance brain scanner designed to accelerate stroke diagnosis and treatment by providing rapid, point-of-care imaging.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.